跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47 条关于
“TG4070”
全部
47
临床试验
27
药物
10
机构
0
资讯
10
10天前
Transgene and ProBioGen Expand Strategic Partnership with Additional License for AGE1.CR.pIX Cell Line
去年
Transgene's TG4050 Shows Promise in Head and Neck Cancer Trial
去年
Transgene and NEC's TG4050 Cancer Vaccine Shows Sustained Disease-Free Survival in Head and Neck Cancer Trial
去年
BMS Partners with Transgene to Test Opdivo-TG4010 Vaccine Combo in PD-L1 Low NSCLC
2年前
Transgene Advances Personalized Cancer Vaccine TG4050 to Phase II Trial in Head and Neck Cancer
去年
TG4050 Neoantigen Vaccine Shows Sustained Disease-Free Survival in Head and Neck Cancer Trial
8个月前
Transgene's TG4050 Achieves 100% Two-Year Disease-Free Survival in Head and Neck Cancer Phase I Trial
去年
Transgene and NEC's TG4050 Shows Sustained Disease-Free Survival in Head and Neck Cancer Trial
去年
Transgene's TG4001 Fails Primary Endpoint in Phase 2 Trial for HPV16-Positive Cancers
去年
Transgene's TG4001 Fails to Meet Primary Endpoint in Phase II Anogenital Cancer Trial